Navigation Links
Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
Date:5/1/2012

ng from HIBM," said Emil D. Kakkis, MD, PhD, Chief Executive Officer of Ultragenyx. "Based on these favorable Phase 1 results, we look forward to moving quickly to initiate a Phase 2 study of UX001." 

Ultragenyx plans to present the Phase 1 data at the 17th Annual International World Muscle Society Congress in Perth, Australia later this year.

About HIBM  

HIBM is also known as GNE myopathy, distal myopathy with rimmed vacuoles (DMRV) and Nonaka disease.  HIBM is a severe, adult-onset, progressive, genetic neuromuscular disease caused by a deficiency of an enzyme in the first step of sialic acid biosynthesis needed for the modification of proteins and fats. Patients with HIBM typically begin to have weakness and abnormal walking at 18 to 30 years of age. Over the ensuing 10 to 20 years, many patients progressively lose significant functional ability and become wheelchair-bound. There are no current treatments for this disease.

About Ultragenyx

Ultragenyx is a privately held, developmental stage biotechnology company committed to bringing life-enhancing therapeutics for patients with rare and ultra-rare genetic diseases, also known as orphan and ultra-orphan diseases, to market.  The company focuses on rare metabolic diseases that affect small numbers of patients, but for which the unmet medical need is high and there are no effective treatments. Ultragenyx intends to build a sustainable pipeline of safe and effective therapies to address these underserved diseases.  Ultragenyx' lead program, UX001, is being evaluated as a potential treatment for hereditary inclusion body myopathy (HIBM), also known as GNE myopathy. 

The company is led by an experienced management team in rare disease therapeutics.  Ultragenyx is striving toward an improved model for successful rare disease drug development which has the potential to increase efficiency while maintaining appropriate sa
'/>"/>

SOURCE Ultragenyx Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ultragenyx Relocates Company Headquarters to Support Operational Expansion
2. Ultragenyx Granted Orphan Designations in Europe for Two Lead Product Candidates, UX001 for HIBM and UX003 for MPS 7
3. Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
4. Ultragenyx Granted Orphan Drug Designation for UX001 SA-ER for the Treatment of Hereditary Inclusion Body Myopathy (HIBM)
5. Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease
6. Acella Pharmaceuticals Announces a New Addition to the Commercial Team
7. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
8. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
9. Rigel Announces First Quarter 2012 Financial Results
10. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
11. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014 Statistics released ... and drunk driving increase astronomically during the holidays, beginning ... in many cities. The data, ... Monitoring Systems as part of their annual ... paints a picture of high-risk drinking and increased rates ...
(Date:11/21/2014)... 21, 2014  Alere Inc. (NYSE: ALR ... appointed Juliet Cunningham as Vice President, Investor ... responsible for driving communications with the investment community. ... of changes to increase shareholder value, it is critical ... Namal Nawana, Chief Executive Officer. "We are delighted that ...
(Date:11/21/2014)... Nov. 21, 2014   Rock Creek Pharmaceuticals, Inc., ... Company is scheduled to present at the Biotech Showcase™ ... on January 12-14, 2015. ... of Rock Creek Pharmaceuticals, will present preclinical and clinical ... which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan will outline ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... EAST HANOVER, N.J., Feb. 1, 2012 Novartis announced ... and Drug Administration (FDA) has approved an update to ... recommend 36 months of treatment after surgery for adult ... met the risk of recurrence inclusion criteria of the ...
... 2012 The U.S. Food and Drug Administration today ... patients following surgical removal of CD117-positive gastrointestinal stromal tumors ... patient survival when the drug is taken for 36 ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ...
Cached Medicine Technology:FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 2FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 3FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 4FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 5FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 6FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 7FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 8FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer 2FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer 3
(Date:11/22/2014)... UWDress.com, a successful wedding dress shop, has released its new ... to prepare for the wedding season. All of them are ... UWDress.com is a reliable company that has many years of ... -- formal wedding guest attire. This new collection comes in ... princess. As one of the leading companies in the wedding ...
(Date:11/22/2014)... Dylan Queen, a renowned brand in wedding dresses, has ... offers a wide range of special occasion dresses, shoes ... to create multiple looks easily. , According to the ... chic wedding dresses has been prepared for many months ... now. Dylan Queen can always create what ladies like, ...
(Date:11/22/2014)... 2014 In order to provide better services, ... cocktail party dresses. The business knows that a suitable cocktail ... , Now, the party dresses supplier’s high quality ... As the leading company in fashion industry, LunaDress understands that ... every customer. So it always raises the professional level and ...
(Date:11/22/2014)... 22, 2014 Domestic farmgate milk ... in 2009-10, due to a fall in demand ... industry products amid the global financial crisis. However, ... of Australian dairy manufacturers on the international scene. ... outweighed supply growth, primarily due to supply constraints ...
(Date:11/22/2014)... 22, 2014 This month has been a ... it has received many positive reviews from some renowned review ... its products by launching a new selection of wonderful sexy ... customers can enjoy free shipping and up to an 80% ... ladies can always find the most suitable dress at Angeldress.co.uk, ...
Breaking Medicine News(10 mins):Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2
... Online counseling through Internet is gaining momentum slowly but surely ... practitioner// and discuss problems of any sort, as they do ... ,If the person being talked to is not visible, it ... or problems. ,"Psychotherapy is treatment for mental or ...
... McDonald seems to have set aside promises of slimmer portions and ... version// of the Big Mac, now to be made 40 percent ... burger, expected to contain at least 690 calories is being introduced ... advertisements have planned for this on television. ,The Latest ...
... that aspirin when taken along with gentamycin can prevent ... ,The results of the study are especially important in ... antibiotics, which includes gentamycin, is commonly used due to ... study has been published in this week's New England ...
... Games have barred Hannah Clark, from Mountain Ash, South Wales, ... heart of 10 years was removed// to allow the working ... to be the first in the UK to have her ... heart was rejected. ,The original transplant operation was ...
... not offer protection against cardiovascular disease, despite the lofty ... trial has shown.// The findings of the trial have ... American Journal of Epidemiology. ,Selenium now joins the ... particular, that were praised for its role in preventing ...
... Professor of Society, Human Development, and Health at Harvard School ... US society //and has found that the disease costs a ... published his research in the new book Understanding Autism: From ... titled, “The Costs of Autism,” Ganz says that autism costs ...
Cached Medicine News:Health News:Anonymity Helps In Overcoming Inhibitions During Online Counseling 2Health News:Aspirin to Prevent Deafness caused by Antibiotics 2Health News:The Price Of Autism 2
... DAPII brain biopsy needle guide housing. ... Screw mount. Placed through a ... Non-sterile; sterilize via autoclave Guide sphere assembly ... with biopsy needles with barium sleeves. Sterile; ...
A complete system of cannulas, needles and rasps specifically designed for inside-out meniscal repair procedures....
Part of the GraFix® Cruciate Reconstruction System, which is designed to facilitate arthroscopic anterior cruciate ligament reconstructions....
... (KGTI) system offers the latest technology and ... The implant system is anatomically designed and ... KGTI is the most advanced reconstructive device ... the market today. The system consists of ...
Medicine Products: